Michael V. Milburn
Vorstandsvorsitzender bei GeneCentric Therapeutics, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Myla Lai-Goldman | M | 66 |
GeneCentric Therapeutics, Inc.
 GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | 13 Jahre |
| Clay Thorp | M | 55 |
GeneCentric Therapeutics, Inc.
GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | - |
| Robert J. Schiller | M | - |
DRUIDapp, Inc.
 DRUIDapp, Inc. Packaged SoftwareTechnology Services DRUIDapp, Inc. engages in the development of a measuring performance impairment tool. The company was founded by Michael V. Milburn in 2016 and is headquartered in Cambridge, MA. | 4 Jahre |
| Charles M. Perou | M | - |
GeneCentric Therapeutics, Inc.
GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | 13 Jahre |
| David Neil Hayes | M | - |
GeneCentric Therapeutics, Inc.
GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | 13 Jahre |
| James Ford | M | - | 29 Jahre | |
| Myla Lai Goldman | F | - |
GeneCentric Therapeutics, Inc.
GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | 3 Jahre |
| John Hayes | M | - |
DRUIDapp, Inc.
DRUIDapp, Inc. Packaged SoftwareTechnology Services DRUIDapp, Inc. engages in the development of a measuring performance impairment tool. The company was founded by Michael V. Milburn in 2016 and is headquartered in Cambridge, MA. | 5 Jahre |
| Arnold Levine | M | 84 |
GeneCentric Therapeutics, Inc.
GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | - |
| Ellen Lubman | F | 48 |
GeneCentric Therapeutics, Inc.
GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | - |
| David Redfern | M | 57 | 30 Jahre | |
| Sally Jackson | F | - | 23 Jahre | |
| Murray M. Dalziel | M | - |
DRUIDapp, Inc.
DRUIDapp, Inc. Packaged SoftwareTechnology Services DRUIDapp, Inc. engages in the development of a measuring performance impairment tool. The company was founded by Michael V. Milburn in 2016 and is headquartered in Cambridge, MA. | - |
| Timothy Woodthorpe | M | - | 24 Jahre | |
| Graham Rivers | M | - | 26 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Timothy Proctor | M | 74 |
Glaxo Wellcome, Inc.
| 6 Jahre |
| George Morrow | M | 72 |
Glaxo Wellcome, Inc.
| 9 Jahre |
| Robert Alexander Ingram | M | 81 |
Glaxo Wellcome, Inc.
| 2 Jahre |
| William Louv | M | - | 21 Jahre | |
| David Savello | M | 78 |
Glaxo Wellcome, Inc.
| 12 Jahre |
| Julian Heslop | M | 70 | 13 Jahre | |
| Alex Howarth | M | 55 | 10 Jahre | |
| Michèle Barzach | M | - | 7 Jahre | |
| Richard Sykes | M | 79 | 7 Jahre | |
| Ian Maurice Gray Prosser | M | 81 | 9 Jahre | |
| Jean-Pierre Garnier | M | 75 | 8 Jahre | |
| John David Coombe | M | 79 | 5 Jahre | |
| Peter Traber | M | 69 | 3 Jahre | |
| Murray Stewart | M | 63 | 17 Jahre | |
| Deborah Waterhouse | F | 57 | - | |
| David Rowe | M | 57 | 20 Jahre | |
| David Wheadon | M | 66 | 5 Jahre | |
| Lawson Macartney | M | 66 | 12 Jahre | |
| Anne Brindley | M | 59 | 3 Jahre | |
| Hu Li | M | 59 | 19 Jahre | |
| Marie Paule Richard | M | 72 | 1 Jahre | |
| Denis Brodsky | M | 53 | 5 Jahre | |
| David M. Pernock | M | 69 | 16 Jahre | |
| Robert J. DiVasto | M | 68 | 2 Jahre | |
| Monica Viziano | M | 57 | 6 Jahre | |
| Carol Ashe | F | 66 | 13 Jahre | |
| Song Gao | M | 52 | 22 Jahre | |
| Duncan Learmouth | M | - | - | |
| Scott Fields | M | 69 | 5 Jahre | |
| Robin M. Young | M | 57 | 7 Jahre | |
| Roger Connor | M | - | 24 Jahre | |
| Michael Owen | M | 73 | 9 Jahre | |
| Michael Allen Luther | M | 67 | 15 Jahre | |
| Vivid Sehgal | M | 56 | 6 Jahre | |
| Daniel G. Marquess | M | 55 | 4 Jahre | |
| Kimberly Park | F | 60 | 12 Jahre | |
| Brian Blakey | M | 61 | 6 Jahre | |
| Dean Hakanson | M | 72 | 7 Jahre | |
| Nick Hirons | M | - | - | |
| James Wu | M | - | 10 Jahre | |
| Thierry Loriot | M | - | - | |
| Edgar Cale | M | 60 | 21 Jahre | |
| Lieven Nuyttens | M | 57 | 6 Jahre | |
| Myra Rosario Herrle | M | - | 9 Jahre | |
| Gregg Brandyberry | M | - | 16 Jahre | |
| John Lepore | M | - | 15 Jahre | |
| Jay C. Strum | M | - | 14 Jahre | |
| Charlie Sanders | M | 91 | 5 Jahre | |
| Douglas B. Snyder | M | 60 | 6 Jahre | |
| Eddie J. Gray | M | 64 | 12 Jahre | |
| Ursula B. Bartels | F | 66 | 11 Jahre | |
| Howard H. Pien | M | 66 | 12 Jahre | |
| Paul W. Hawran | M | 71 | 9 Jahre | |
| Ronaldo Hermann Schmitz | M | 85 | 9 Jahre | |
| Michael D. Rogers | M | 68 | 6 Jahre | |
| Joseph M. Spagnardi | M | 60 | 11 Jahre | |
| Christopher Chipman | M | 50 | 2 Jahre | |
| Maxine Gowen | M | 66 | 10 Jahre | |
| Martin Rosenberg | M | 78 | 5 Jahre | |
| James R. Beery | M | 83 | 1 Jahre | |
| Robert Ruffolo | M | 74 | 16 Jahre | |
| Dean Mitchell | M | 68 | 15 Jahre | |
| Roger L. Hawley | M | 71 | 14 Jahre | |
| Joseph Schachle | M | 59 | 3 Jahre | |
| Margaret Dalesandro | M | 77 | 2 Jahre | |
| Tamar Howson | F | 75 | 9 Jahre | |
| Lucy Shapiro | M | 83 | 5 Jahre | |
| Franco di Muzio | M | - | 8 Jahre | |
| Ford Calhoun | M | - | - | |
| Paul Carter | M | 63 | 10 Jahre | |
| Christopher J. Morl | M | 65 | 3 Jahre | |
| Dimitri Dimitriou | M | - | 5 Jahre | |
| Peter Strong | M | - | 3 Jahre | |
| David Lawrence | M | 61 | 13 Jahre | |
| Rupert Bondy | M | 62 | - | |
| Adrian Rawcliffe | M | 52 | 17 Jahre | |
| Ian Gilham | M | 64 | - | |
| Lisa Porter | M | 60 | 5 Jahre | |
| Ed Mathers Mathers | M | 64 |
Glaxo Wellcome, Inc.
| 3 Jahre |
| Elaine Jones | M | 69 | - | |
| Gary Patou | M | 65 | 5 Jahre | |
| Leon Palandjian | M | 54 | 3 Jahre | |
| Geoffrey Nichol | M | 69 | 7 Jahre | |
| Paul Magrez | M | - | 4 Jahre | |
| Wissam Al-Adani | M | 50 | 6 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigtes Königreich | 85 | 85,00% |
| Vereinigte Staaten | 15 | 15,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Michael V. Milburn
- Persönliches Netzwerk
